Panani, Jacklee -.
HRN: 24-96-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2024
CEFTRIAXONE 1G (VIAL)
04/29/2024
05/06/2024
IV
600mg
Q12
Fracture, Lacerations
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes